Labcorp cuts research unit’s growth prospects as biotech funding crisis persists

Labcorp cuts research unit’s growth prospects as biotech funding crisis persists

By Puyaan Singh and Sahil Pandey (Reuters) -Labcorp on Tuesday forecast lower annual revenue growth for its contract research unit as a prolonged funding crisis continues to weigh on its early-stage drug development clients. Contract research firms have witnessed reduced spending from biotech clients over the past two years. The funding crisis, which was expected…

Read More